EUVIMEDOpdag EUVIMED
Crossref

Inhibition of Pyruvate Dehydrogenase Kinase 2 Alleviates Concanavalin A‐Induced Acute Liver Injury by Regulating Myeloid‐Derived Suppressor Cells

Chunxia Li iD, Chenyu Li, Weiwei Zhai, Ruihan Yu, Xinyi Xu, Fenglian Yan, Hui Zhang, Junfeng Zhang, Mingsheng Zhao iD, Lin Wang, Yuanbo Zhu, Zhihong Liu and 3 more

Immunology · 2026

DOI: 10.1111/imm.70053 ↗

At a glance

Journal article in Immunology, 2026. Written by Chunxia Li and 14 co-authors. Institution: Institute of Immunology and Molecular Medicine, Basic Medical School, Jining Medical University, Jining, People's Republic of China. Major MEDLINE topics: Pyruvate Dehydrogenase Acetyl-Transferring Kinase, Chemical and Drug Induced Liver Injury, Myeloid-Derived Suppressor Cells, Protein Kinase Inhibitors. 59 references. Funded by: the National Natural Science Foundation of China, the Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation at Jining Medical University, the Undergraduate Innovation Training Program of Jining Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Pyruvate dehydrogenase kinase 2 (PDK2) regulates glucose metabolism; however, its role in liver injury development is unknown. Therefore, this study aimed to explore the effects of PDK2 on liver injury using a concanavalin A (Con A)‐induced acute liver injury mouse model. To understand the mechanisms by which PDK2 affects liver injury pathogenesis, network pharmacology analysis was performed to pinpoint the potential target genes and signaling pathways involved. Con A was used to induce acute liver injury in mice. Thereafter, PDK2 differential expression levels in the liver tissue of normal and liver injury mice were analyzed, and the effects of PDK2 inhibition on Con A‐induced liver damage were assessed through biochemical analysis and observation of hepatic histopathological changes. Enzyme‐linked immunosorbent assay, quantitative polymerase chain reaction, flow cytometry, and western blotting were used to explore the possible mechanisms by which PDK2 affects liver injury. PDK2 was involved in liver injury progression, and pharmacological inhibition of PDK2 notably increased mouse survival, decreased serum alanine transaminase and aspartate aminotransferase levels, attenuated hepatic histopathological damage and apoptosis, and inhibited pro‐inflammatory cytokine secretion and the activation of the mitogen‐activated protein kinase/nuclear factor kappa B (MAPK/NF‐κB) signaling pathway. Pharmacological inhibition of PDK2 markedly alleviated hepatic oxidative stress and elevated myeloid‐derived suppressor cells (MDSCs) in the livers of acute liver injury mice. Overall, inhibiting PDK2 ameliorates Con A‐induced acute liver injury by enhancing MDSCs accumulation and suppressing oxidative stress, the MAPK/NF‐κB signaling pathway, and inflammation. These findings identify PDK2 as a promising therapeutic target for immune‐mediated hepatitis.

Subjects

MeSH terms (MEDLINE)

Pyruvate Dehydrogenase Acetyl-Transferring KinaseChemical and Drug Induced Liver InjuryMyeloid-Derived Suppressor CellsProtein Kinase InhibitorsAnimalsConcanavalin AMiceDisease Models, AnimalMaleLiverCytokinesSignal TransductionNF-kappa BApoptosis

Author keywords

concanavalin Ahepatic injuryinflammationmyeloid‐derived suppressor cellspyruvate dehydrogenase kinase 2

Substances

Concanavalin APyruvate Dehydrogenase Acetyl-Transferring KinasePdk2 protein, mouseCytokinesNF-kappa BProtein Kinase Inhibitors

Authors and institutions

  • Institute of Immunology and Molecular Medicine, Basic Medical School, Jining Medical University, Jining, People's Republic of China.
  • Department of Clinical Laboratory, Jining No. 1 People's Hospital, Jining, People's Republic of China.

ORCID profiles: Chunxia Li, Mingsheng Zhao

Funding

  • the National Natural Science Foundation of China
  • the Research Fund for Lin He's Academician Workstation of New Medicine and Clinical Translation at Jining Medical University
  • the Undergraduate Innovation Training Program of Jining Medical University
  • National Natural Science Foundation of China

Cite

APA

Li, C., Li, C., Zhai, W., Yu, R., Xu, X., Yan, F., Zhang, H., Zhang, J., Zhao, M., Wang, L., Zhu, Y., Liu, Z., Yang, Z., Li, W., & Xiong, H. (2026). Inhibition of Pyruvate Dehydrogenase Kinase 2 Alleviates Concanavalin A‐Induced Acute Liver Injury by Regulating Myeloid‐Derived Suppressor Cells. Immunology. https://doi.org/10.1111/imm.70053

Vancouver

Li C, Li C, Zhai W, Yu R, Xu X, Yan F, et al. Inhibition of Pyruvate Dehydrogenase Kinase 2 Alleviates Concanavalin A‐Induced Acute Liver Injury by Regulating Myeloid‐Derived Suppressor Cells. Immunology. 2026. doi:10.1111/imm.70053

BibTeX
@article{Li2026,
  author = {Li, Chunxia and Li, Chenyu and Zhai, Weiwei and Yu, Ruihan and Xu, Xinyi and Yan, Fenglian and Zhang, Hui and Zhang, Junfeng and Zhao, Mingsheng and Wang, Lin and Zhu, Yuanbo and Liu, Zhihong and Yang, Zhuoqun and Li, Wenbo and Xiong, Huabao},
  title = {Inhibition of Pyruvate Dehydrogenase Kinase 2 Alleviates Concanavalin A‐Induced Acute Liver Injury by Regulating Myeloid‐Derived Suppressor Cells},
  journal = {Immunology},
  year = {2026},
  doi = {10.1111/imm.70053}
}
Start for free →